Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Osterlund

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Lancet Regional Health. Europe|September 24, 2021
Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial - Authors' replyPia Osterlund, Helena Isoniemi
Duodecim; Laaketieteellinen Aikakauskirja|March 15, 2013
[Conservative treatment for inoperable malign intestinal obstruction]Tiina Saarto, Pia Osterlund, Anna Lepistö
Anticancer Research|December 26, 2012
CEA fluctuation during a single fluorouracil-based chemotherapy cycle for metastatic colorectal cancerKethe Hermunen, Caj Haglund, Pia Osterlund
Duodecim; Laaketieteellinen Aikakauskirja|January 24, 2007
[Not Available]Pia Osterlund, Raija Ristamäki, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja|September 1, 2010
[Treatment of pseudomyxoma peritonei is developing]Anna Lepistö, Pia Osterlund, Heikki J Järvinen
Duodecim; Laaketieteellinen Aikakauskirja|May 6, 2009
[Colonic carcinoma]Pia Osterlund, Anna Lepistö, Heikki J Järvinen
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert reportPeter Nygren, Halfdan Sørbye, Pia Osterlund, et al.
Duodecim; Laaketieteellinen Aikakauskirja|June 5, 2009
[Rectal cancer]Anna Lepistö, Pia Osterlund, Mauri Kouri, et al.
Oncotargets and Therapy|July 26, 2014
A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resectionPia Osterlund, Reetta Peltonen, Tuomo Alanko, et al.
International Journal of Colorectal Disease|October 19, 2011
Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colonReetta Holma, Pia Osterlund, Ulla Sairanen, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Lancet Regional Health. Europe|September 24, 2021
Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial - Authors' replyPia Osterlund, Helena Isoniemi
Duodecim; Laaketieteellinen Aikakauskirja|March 15, 2013
[Conservative treatment for inoperable malign intestinal obstruction]Tiina Saarto, Pia Osterlund, Anna Lepistö
Anticancer Research|December 26, 2012
CEA fluctuation during a single fluorouracil-based chemotherapy cycle for metastatic colorectal cancerKethe Hermunen, Caj Haglund, Pia Osterlund
Duodecim; Laaketieteellinen Aikakauskirja|January 24, 2007
[Not Available]Pia Osterlund, Raija Ristamäki, Seppo Pyrhönen
Duodecim; Laaketieteellinen Aikakauskirja|September 1, 2010
[Treatment of pseudomyxoma peritonei is developing]Anna Lepistö, Pia Osterlund, Heikki J Järvinen
Duodecim; Laaketieteellinen Aikakauskirja|May 6, 2009
[Colonic carcinoma]Pia Osterlund, Anna Lepistö, Heikki J Järvinen
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert reportPeter Nygren, Halfdan Sørbye, Pia Osterlund, et al.
Duodecim; Laaketieteellinen Aikakauskirja|June 5, 2009
[Rectal cancer]Anna Lepistö, Pia Osterlund, Mauri Kouri, et al.
Oncotargets and Therapy|July 26, 2014
A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resectionPia Osterlund, Reetta Peltonen, Tuomo Alanko, et al.
International Journal of Colorectal Disease|October 19, 2011
Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colonReetta Holma, Pia Osterlund, Ulla Sairanen, et al.
Pageof 5